124 related articles for article (PubMed ID: 9390200)
1. Intrapleural instillation of interferon gamma in patients with malignant pleurisy due to lung cancer.
Yanagawa H; Haku T; Hiramatsu K; Nokihara H; Takeuchi E; Yano S; Hanibuchi M; Sone S
Cancer Immunol Immunother; 1997 Oct; 45(2):93-9. PubMed ID: 9390200
[TBL] [Abstract][Full Text] [Related]
2. Intrapleural therapy with MDP-Lys (L18), a synthetic derivative of muramyl dipeptide, against malignant pleurisy associated with lung cancer.
Yanagawa H; Haku T; Takeuchi E; Suzuki Y; Nokihara H; Sone S
Lung Cancer; 2000 Feb; 27(2):67-73. PubMed ID: 10688489
[TBL] [Abstract][Full Text] [Related]
3. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer.
Yasumoto K; Mivazaki K; Nagashima A; Ishida T; Kuda T; Yano T; Sugimachi K; Nomoto K
Cancer Res; 1987 Apr; 47(8):2184-7. PubMed ID: 3493843
[TBL] [Abstract][Full Text] [Related]
4. Intrapleural application of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. A multi-institutional cooperative study.
Yasumoto K; Ogura T
Biotherapy; 1991; 3(4):345-9. PubMed ID: 1786198
[TBL] [Abstract][Full Text] [Related]
5. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
Kang MQ; Cao YP; Deng F
Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions.
Okamoto M; Kawabe T; Iwasaki Y; Hara T; Hashimoto N; Imaizumi K; Hasegawa Y; Shimokata K
J Lab Clin Med; 2005 Feb; 145(2):88-93. PubMed ID: 15746651
[TBL] [Abstract][Full Text] [Related]
7. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.
Okamoto M; Hasegawa Y; Hara T; Hashimoto N; Imaizumi K; Shimokata K; Kawabe T
Chest; 2005 Dec; 128(6):4030-5. PubMed ID: 16354877
[TBL] [Abstract][Full Text] [Related]
8. [Induction by local injections of IL-2 of antitumor effector cells and secondary production of cytokines in malignant pleural effusion].
Sone S; Yanagawa H; Nii A; Ozaki T; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1434-40. PubMed ID: 1434216
[TBL] [Abstract][Full Text] [Related]
9. An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer.
Chen YM; Yang WK; Whang-Peng J; Tsai CM; Perng RP
Lung Cancer; 2001 Jan; 31(1):25-30. PubMed ID: 11162863
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of tuberculous pleurisy by measurement of cytokine concentrations in pleural effusion.
Ogawa K; Koga H; Hirakata Y; Tomono K; Tashiro T; Kohno S
Tuber Lung Dis; 1997; 78(1):29-34. PubMed ID: 9666960
[TBL] [Abstract][Full Text] [Related]
11. IL-6 in malignant pleural effusions and its augmentation by intrapleural instillation of IL-2.
Yanagawa H; Sone S; Munekata M; Atagi S; Nii A; Ogura T
Clin Exp Immunol; 1992 May; 88(2):207-12. PubMed ID: 1315227
[TBL] [Abstract][Full Text] [Related]
12. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
Sterman DH; Recio A; Carroll RG; Gillespie CT; Haas A; Vachani A; Kapoor V; Sun J; Hodinka R; Brown JL; Corbley MJ; Parr M; Ho M; Pastan I; Machuzak M; Benedict W; Zhang XQ; Lord EM; Litzky LA; Heitjan DF; June CH; Kaiser LR; Vonderheide RH; Albelda SM; Kanther M
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4456-66. PubMed ID: 17671130
[TBL] [Abstract][Full Text] [Related]
13. Interferon instillation for malignant pleural effusions.
Goldman CA; Skinnider LF; Maksymiuk AW
Ann Oncol; 1993 Feb; 4(2):141-5. PubMed ID: 8448082
[TBL] [Abstract][Full Text] [Related]
14. [A study on the model of tuberculous pleurisy and intrapleural inflammatory and immunological responses in rats].
He Q; Xie CM; Tan SY; Zhang KX; Deng XH; Zhu PB; Yi XP; Zhang YL; Cai XS; Huang LJ; Liu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):117-21. PubMed ID: 15854395
[TBL] [Abstract][Full Text] [Related]
15. Combined detections of interleukin 27, interferon-γ, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy.
Wu YB; Ye ZJ; Qin SM; Wu C; Chen YQ; Shi HZ
Chin Med J (Engl); 2013; 126(17):3215-21. PubMed ID: 24033939
[TBL] [Abstract][Full Text] [Related]
16. Exogenous intrapleural injection of interleukin-27 may improves outcome and prognosis in patients with tuberculous pleural effusion.
Gan Y; Guo S; Zhu Y; Jiang J; Tan Y
Med Hypotheses; 2019 Oct; 131():109319. PubMed ID: 31443751
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions.
Sartori S; Tassinari D; Ceccotti P; Tombesi P; Nielsen I; Trevisani L; Abbasciano V
J Clin Oncol; 2004 Apr; 22(7):1228-33. PubMed ID: 15051770
[TBL] [Abstract][Full Text] [Related]
18. Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients.
Castagneto B; Zai S; Mutti L; Lazzaro A; Ridolfi R; Piccolini E; Ardizzoni A; Fumagalli L; Valsuani G; Botta M
Lung Cancer; 2001; 31(2-3):303-10. PubMed ID: 11165411
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic significance of gamma-interferon in tuberculous pleurisy.
Poyraz B; Kaya A; Ciledağ A; Oktem A; Gönüllü U
Tuberk Toraks; 2004; 52(3):211-7. PubMed ID: 15351932
[TBL] [Abstract][Full Text] [Related]
20. Activation of Valpha24NKT cells in malignant pleural effusion in patients with lung cancer.
Shimizu T; Takahashi N; Terakado M; Tsujino I; Hashimoto S
Oncol Rep; 2009 Sep; 22(3):581-6. PubMed ID: 19639207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
